Medicus Pharma LTD -29 (MDCXW) — 13F Holders Deep Dive (Q2 2026)

MDCXW ranks #12678 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

4 institutions disclose a position in MDCXW, but none treat it as a major bet — even Armistice Capital, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Anson Funds Management LP has trimmed its MDCXW position for two straight quarters, cutting it by $45.9K while still holding $18.9K.

MDCXW reported a net loss of $47.3M in its latest fiscal year.

• Not yet profitable — net loss of $47.3M in the latest fiscal year
• Net income declined year over year, from -$11.2M to -$47.3M
• Operating cash flow was negative, using $22.8M in cash
• Current ratio of 1.00x — below the conventional 1.5x liquidity buffer
• Total liabilities currently exceed total assets (negative shareholder equity)